Fully updated information on diagnosis and management of IPF, including six new chapters
Includes new coverage of interstitial lung disease classification, biomarkers in IPF, new concepts in disease pathogenesis, and the genetic underpinnings of the disease
Written by an international group of expert authors
Rezensionen / Stimmen
"This is likely one of the most comprehensive and complete books on idiopathic pulmonary fibrosis currently available, and it should be extremely useful to pulmonologists and researchers who are interested in the pathogenesis, diagnosis, and treatment of this fatal disease." (Santosh Dhungana, Doody's Book Reviews, April 26, 2019)
Reihe
Auflage
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Zielgruppe
Editions-Typ
Illustrationen
50
29 s/w Abbildungen, 50 farbige Abbildungen
XVII, 475 p. 79 illus., 50 illus. in color.
Maße
Höhe: 241 mm
Breite: 160 mm
Dicke: 31 mm
Gewicht
ISBN-13
978-3-319-99974-6 (9783319999746)
DOI
10.1007/978-3-319-99975-3
Schweitzer Klassifikation
Keith C. Meyer, MD is a professor of pulmonary and critical care medicine at the University of Wisconsin School of Medicine and Public Health. He is volume editor of three successful Springer books: Idiopathic Pulmonary Fibrosis, Gastroesophageal Reflux and the Lung, and Bronchiolitis Obliterans Syndrome in Lung Transplantation.
Steven D. Nathan, MD is professor of medicine at Virginia Commonwealth University Inova Campus and director of the Lung Transplant and Advanced Lung Disease programs. He is also volume editor of Idiopathic Pulmonary Fibrosis and the upcoming Guide to Clinical Management of Idiopathic Pulmonary Fibrosis (with Springer Healthcare)
